Log in to save to my catalogue

Identification of SARS-CoV-2 inhibitors using lung and colonic organoids

Identification of SARS-CoV-2 inhibitors using lung and colonic organoids

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8034380

Identification of SARS-CoV-2 inhibitors using lung and colonic organoids

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

There is an urgent need to create novel models using human disease-relevant cells to study severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) biology and to facilitate drug screening. Here, as SARS-CoV-2 primarily infects the respiratory tract, we developed a lung organoid model using human pluripotent stem cells (hPSC-LOs). The hPSC-LOs...

Alternative Titles

Full title

Identification of SARS-CoV-2 inhibitors using lung and colonic organoids

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8034380

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8034380

Other Identifiers

ISSN

0028-0836,1476-4687

E-ISSN

1476-4687

DOI

10.1038/s41586-020-2901-9

How to access this item